New Ovarian Cancer Drugs Raise Hope — But Not For All

July 6, 2016 6:25 pm

Promising new therapies are springing up to treat ovarian cancer, long one of the most deadly and hard to treat malignancies. The latest: An experimental drug from Tesaro, a small biotech company based in Waltham, Mass. The company on Wednesday … Read more

Eating After a Cancer Diagnosis: Does What You Eat Really Matter?

July 5, 2016 8:42 pm

With the number of cancer survivors growing every day, the question of what to eat after a cancer diagnosis is quickly becoming a hot topic. Some survivors believe it is of little importance: they have already been through cancer, so … Read more

TESARO’s Niraparib Significantly Improved Progression-Free Survival

June 29, 2016 7:03 pm

TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the Phase 3 NOVA trial of niraparib successfully achieved its primary endpoint of progression-free survival (PFS). This trial demonstrated that niraparib significantly prolonged PFS compared to control among patients who … Read more

Biden: Moonshot Requires ‘Open Collaboration, Open Minds’

June 14, 2016 5:56 pm

Increased collaboration and a willingness to see beyond the expected will be critical to the success of the national cancer moonshot initiative, Vice President Joe Biden told ASCO Annual Meeting attendees this afternoon. “No single oncologist or cancer researcher can … Read more

Precision Medicine and Cancer

June 8, 2016 7:16 pm

ASCO’s (American Society of Clinical Oncology) Annual Meeting was held on June 2nd through June 7th in Chicago, Illinois. ASCO offers premier scientific events for oncology professionals, patients, patient advocates, industry representatives, and major media outlets worldwide. It showcased new … Read more

Combination Of Chemotherapy And Immunotherapy May Be Effective

June 8, 2016 7:04 pm

Inside each ovarian tumor, there are good cells and bad cells. A new paper explains their roles: The bad cells are fibroblasts. They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment. … Read more

Precision Medicine Yields Better Outcomes for Clinical Trial Patients

June 2, 2016 6:21 pm

A meta-analysis of 346 phase I clinical trials involving more than 13,000 patients found that patients whose treatment was selected based on the molecular characteristics of their tumor had significantly better outcomes. The study was featured in a press briefing … Read more

8 Things Every Woman Needs To Know About Ovarian Cancer

May 17, 2016 6:32 pm

“Ovarian cancer is the most feared gynecologic cancer,” says Teresa Diaz-Montes, MD, associate director of the Lya Segall Ovarian Cancer Institute at Mercy Medical Center in Baltimore, MD. Perhaps that’s for good reason: Often called the “silent killer,” the disease … Read more

Marijuana Benefits, Risks For Patients With Cancer Need More Study

May 9, 2016 8:13 pm

Even as an increasing number of states approve the use of medical marijuana, a review of medical literature and existing data finds that huge questions remain about its true benefits and risks for patients with cancer.Investigators found that … Read more

Scalp Cooling Safe, Long-term European Data Show

May 4, 2016 6:31 pm

For cancer patients undergoing alopecia-inducing chemotherapy, scalp cooling to reduce hair loss is safe, according to new research. “This is a treatment that women going into chemotherapy treatment need to know about,” said Mikel Ross, RN, BSN, from the Memorial … Read more

Biden Discusses Future Of Cancer Research In New Orleans

April 21, 2016 6:11 pm

Three years ago, Vice President Joe Biden was sitting with President Xi Jinping of China in an empty restaurant in the city of Chengdu. Speaking through a translator, Xi asked him whether he could “define America.” Biden told Xi he … Read more

Highlights from Society of Gynecologic Oncology (SGO 2016)

April 4, 2016 6:42 pm

Women’s cancer specialists from all over the world convened in San Diego in March to hear about the latest developments in women’s cancer research. This was the fifth SGO annual meeting I’ve attended over the past eight years, and the … Read more

6 Commonly Missed Signs Of Ovarian Cancer: The Silent Killer

March 14, 2016 7:18 pm

An estimated 22,280 women in the United States will be diagnosed with ovarian cancer this year and 14,240 women will die. Unfortunately, most women are not aware of the dangers or symptoms of ovarian cancer, and many realize they have … Read more